mRNA vaccines have revolutionized vaccine development against infectious diseases, as demonstrated by the rapid creation and deployment of vaccines for SARS-CoV-2. In this chapter, we present a protocol for the generation of mRNA vaccine formulations utilizing lipid nanoparticle-based delivery systems. Additionally, we provide guidance for the evaluation of (i) mRNA formulation immunogenicity, (ii) mRNA formulation induced antigen cross-presentation, and (iii) antigen-specific CD8+ T-cell responses post in vivo vaccination.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Generation of Lipid Nanoparticle mRNA Vaccines and Evaluation of Antigen-Specific CD8+ T-Cell Responses

  • Ross W. Ward,
  • Aparna Ananthanarayanan,
  • Nina Bhardwaj,
  • Nicolas Vabret

摘要

mRNA vaccines have revolutionized vaccine development against infectious diseases, as demonstrated by the rapid creation and deployment of vaccines for SARS-CoV-2. In this chapter, we present a protocol for the generation of mRNA vaccine formulations utilizing lipid nanoparticle-based delivery systems. Additionally, we provide guidance for the evaluation of (i) mRNA formulation immunogenicity, (ii) mRNA formulation induced antigen cross-presentation, and (iii) antigen-specific CD8+ T-cell responses post in vivo vaccination.